Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab

Mayumi Nagata; Masahiro Kamata; Saki Fukaya; Kotaro Hayashi; Atsuko Fukuyasu; Takamitsu Tanaka; Takeko Ishikawa; Takamitsu Ohnishi; Kazumitsu Sugiura; Yayoi Tada

doi:10.1016/j.jaad.2019.09.040

Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab

Mayumi Nagata
, Masahiro Kamata
, Saki Fukaya
, Kotaro Hayashi
, Atsuko Fukuyasu
, Takamitsu Tanaka
, Takeko Ishikawa
, Takamitsu Ohnishi
, Kazumitsu Sugiura
, Yayoi Tada

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

本文言語	英語
ページ（範囲）	758-761
ページ数	4
ジャーナル	Journal of the American Academy of Dermatology
巻	82
号	3
DOI	https://doi.org/10.1016/j.jaad.2019.09.040
出版ステータス	出版済み - 03-2020
外部発表	はい

All Science Journal Classification (ASJC) codes

皮膚病学

文献へのアクセス

10.1016/j.jaad.2019.09.040

他のファイルとリンク

引用スタイル

@article{48fe43e1b25649efad0527d15ea3779b,

title = "Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab",

author = "Mayumi Nagata and Masahiro Kamata and Saki Fukaya and Kotaro Hayashi and Atsuko Fukuyasu and Takamitsu Tanaka and Takeko Ishikawa and Takamitsu Ohnishi and Kazumitsu Sugiura and Yayoi Tada",

note = "Funding Information: Disclosure: Dr Kamata received grants for research from Torii Pharmaceutical, Eisai, Maruho, and Novartis Pharma and honoraria for lectures from Torii Pharmaceutical, Maruho, LEO Pharma, Eisai, AbbVie, Kyowa Hakko Kirin, Eli Lilly, Taiho Pharmaceutical, Mitsubishi Tanabe Pharma, and Janssen Pharmaceuticals.Dr Tada received grants for research from Maruho, LEO Pharma, Eisai, AbbVie, Kyowa Hakko Kirin, Taiho Pharmaceutical, Celgene, and Eli Lilly and honoraria for lectures from Torii Pharmaceutical, Maruho, LEO Pharma, Eisai, AbbVie, Kyowa Hakko Kirin, Eli Lilly, Taiho Pharmaceutical, Mitsubishi Tanabe Pharma, and Janssen Pharmaceuticals. Drs Nagata, Fukaya, Hayashi, Fukuyasu, Tanaka, Ishikawa, Ohnishi, and Sugiura have no conflicts of interest to declare. Funding sources: None.",

year = "2020",

month = mar,

doi = "10.1016/j.jaad.2019.09.040",

language = "English",

volume = "82",

pages = "758--761",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab

AU - Nagata, Mayumi

AU - Kamata, Masahiro

AU - Fukaya, Saki

AU - Hayashi, Kotaro

AU - Fukuyasu, Atsuko

AU - Tanaka, Takamitsu

AU - Ishikawa, Takeko

AU - Ohnishi, Takamitsu

AU - Sugiura, Kazumitsu

AU - Tada, Yayoi

N1 - Funding Information: Disclosure: Dr Kamata received grants for research from Torii Pharmaceutical, Eisai, Maruho, and Novartis Pharma and honoraria for lectures from Torii Pharmaceutical, Maruho, LEO Pharma, Eisai, AbbVie, Kyowa Hakko Kirin, Eli Lilly, Taiho Pharmaceutical, Mitsubishi Tanabe Pharma, and Janssen Pharmaceuticals.Dr Tada received grants for research from Maruho, LEO Pharma, Eisai, AbbVie, Kyowa Hakko Kirin, Taiho Pharmaceutical, Celgene, and Eli Lilly and honoraria for lectures from Torii Pharmaceutical, Maruho, LEO Pharma, Eisai, AbbVie, Kyowa Hakko Kirin, Eli Lilly, Taiho Pharmaceutical, Mitsubishi Tanabe Pharma, and Janssen Pharmaceuticals. Drs Nagata, Fukaya, Hayashi, Fukuyasu, Tanaka, Ishikawa, Ohnishi, and Sugiura have no conflicts of interest to declare. Funding sources: None.

PY - 2020/3

Y1 - 2020/3

UR - https://www.scopus.com/pages/publications/85078037641

UR - https://www.scopus.com/pages/publications/85078037641#tab=citedBy

U2 - 10.1016/j.jaad.2019.09.040

DO - 10.1016/j.jaad.2019.09.040

M3 - Article

C2 - 31560979

AN - SCOPUS:85078037641

SN - 0190-9622

VL - 82

SP - 758

EP - 761

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 3

ER -